Elutia Inc reports results for the quarter ended June 30 - Earnings Summary

• Elutia Inc ELUT.OQ reported a quarterly adjusted loss of 23 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.13. The mean expectation of two analysts for the quarter was for a loss of 17 cents per share. Wall Street expected results to range from -18 cents to -16 cents per share.

• Revenue fell 0.4% to $6.26 million from a year ago; analysts expected $6.55 million.

• Elutia Inc's reported EPS for the quarter was a loss of 23 cents​.

• The company reported a quarterly loss of $9.61 million.

• Elutia Inc shares had risen by 8.6% this quarter and lost 42.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Elutia Inc is $7.50, about 71.3% above its last closing price of $2.15

This summary was machine generated from LSEG data August 15 at 06:14 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)